SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay
SARS-CoV-2抗体的浓度和可检测性受疾病严重程度、发病时间和检测方法的影响。
期刊:Science Advances
影响因子:12.5
doi:10.1126/sciadv.abh3409
Peluso, Michael J; Takahashi, Saki; Hakim, Jill; Kelly, J Daniel; Torres, Leonel; Iyer, Nikita S; Turcios, Keirstinne; Janson, Owen; Munter, Sadie E; Thanh, Cassandra; Donatelli, Joanna; Nixon, Christopher C; Hoh, Rebecca; Tai, Viva; Fehrman, Emily A; Hernandez, Yanel; Spinelli, Matthew A; Gandhi, Monica; Palafox, Mary-Ann; Vallari, Ana; Rodgers, Mary A; Prostko, John; Hackett, John Jr; Trinh, Lan; Wrin, Terri; Petropoulos, Christos J; Chiu, Charles Y; Norris, Philip J; DiGermanio, Clara; Stone, Mars; Busch, Michael P; Elledge, Susanna K; Zhou, Xin X; Wells, James A; Shu, Albert; Kurtz, Theodore W; Pak, John E; Wu, Wesley; Burbelo, Peter D; Cohen, Jeffrey I; Rutishauser, Rachel L; Martin, Jeffrey N; Deeks, Steven G; Henrich, Timothy J; Rodriguez-Barraquer, Isabel; Greenhouse, Bryan